These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25396262)

  • 1. Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland.
    Gueler A; Schoeni-Affolter F; Moser A; Bertisch B; Bucher HC; Calmy A; Cavassini M; Ledergerber B; Wandeler G; Egger M;
    AIDS; 2015 Jan; 29(2):231-8. PubMed ID: 25396262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Swiss neighbourhood index of socioeconomic position: development and association with mortality.
    Panczak R; Galobardes B; Voorpostel M; Spoerri A; Zwahlen M; Egger M;
    J Epidemiol Community Health; 2012 Dec; 66(12):1129-36. PubMed ID: 22717282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What does your neighbourhood say about you? A study of life expectancy in 1.3 million Swiss neighbourhoods.
    Moser A; Panczak R; Zwahlen M; Clough-Gorr KM; Spoerri A; Stuck AE; Egger M;
    J Epidemiol Community Health; 2014 Dec; 68(12):1125-32. PubMed ID: 25124188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic position and the COVID-19 care cascade from testing to mortality in Switzerland: a population-based analysis.
    Riou J; Panczak R; Althaus CL; Junker C; Perisa D; Schneider K; Criscuolo NG; Low N; Egger M
    Lancet Public Health; 2021 Sep; 6(9):e683-e691. PubMed ID: 34252364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord.
    ; Lodi S; Dray-Spira R; Touloumi G; Braun D; Teira R; D'Arminio Monforte A; Gallois A; Zangerle R; Spire B; Dabis F; Stähelin C; Termote M; Kirk O; Chêne G; Egger M; del Amo J
    AIDS; 2014 Sep; 28(15):2297-306. PubMed ID: 25313585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Swiss neighbourhood index of socioeconomic position: update and re-validation.
    Panczak R; Berlin C; Voorpostel M; Zwahlen M; Egger M
    Swiss Med Wkly; 2023 Jan; 153():40028. PubMed ID: 36652707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study.
    Thierfelder C; Weber R; Elzi L; Furrer H; Cavassini M; Calmy A; Bernasconi E; Gutmann C; Ledergerber B;
    HIV Med; 2012 Feb; 13(2):118-26. PubMed ID: 22107170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
    Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
    Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
    Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
    AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era.
    El Amari EB; Toutous-Trellu L; Gayet-Ageron A; Baumann M; Cathomas G; Steffen I; Erb P; Mueller NJ; Furrer H; Cavassini M; Vernazza P; Hirsch HH; Bernasconi E; Hirschel B;
    AIDS; 2008 May; 22(9):1019-28. PubMed ID: 18520345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of neighbourhood unemployment on health-risk behaviours in elderly differs between Slovak and Dutch cities.
    Behanova M; Katreniakova Z; Nagyova I; van Ameijden EJ; Dijkshoorn H; van Dijk JP; Reijneveld SA
    Eur J Public Health; 2015 Feb; 25(1):108-14. PubMed ID: 25085473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neighbourhood socioeconomic position and risks of major chronic diseases and all-cause mortality: a quasi-experimental study.
    Kim D; Glazier RH; Zagorski B; Kawachi I; Oreopoulos P
    BMJ Open; 2018 May; 8(5):e018793. PubMed ID: 29780025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short communication: effects of age on virologic suppression and CD4 cell response in HIV-positive patients initiating combination antiretroviral therapy.
    Szadkowski L; Tseng A; Walmsley SL; Salit I; Raboud JM
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1579-83. PubMed ID: 22734840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological control during the first 6-18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: a Danish, population-based, 6-year follow-up study.
    Lohse N; Kronborg G; Gerstoft J; Larsen CS; Pedersen G; Pedersen C; Sørensen HT; Obel N
    Clin Infect Dis; 2006 Jan; 42(1):136-44. PubMed ID: 16323104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
    Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
    Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients who present late to HIV care and associated risk factors in Nigeria.
    Agaba PA; Meloni ST; Sule HM; Agbaji OO; Ekeh PN; Job GC; Nyango N; Ugoagwu PO; Imade GE; Idoko JA; Kanki PJ
    HIV Med; 2014 Aug; 15(7):396-405. PubMed ID: 24580742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily.
    Celesia BM; Castronuovo D; Pinzone MR; Bellissimo F; Mughini MT; Lupo G; Scarpino MR; Gussio M; Palermo F; Cosentino S; Cacopardo B; Nunnari G
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2218-24. PubMed ID: 23893189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study.
    Staehelin C; Keiser O; Calmy A; Weber R; Elzi L; Cavassini M; Schmid P; Bernasconi E; Furrer H;
    J Acquir Immune Defic Syndr; 2012 Jan; 59(1):79-85. PubMed ID: 21937923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.